Indeed, blocking these checkpoints may favor the prognosis of ccRCC patients, since depletion of immune cells, namely CD8+ cells, was associated with worse clinical outcome in a recent report based on transcriptomic analysis [37]. The gene discussed is CD8A; the disease is nonpapillary renal cell carcinoma.